(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. Mutant brain phenotype observed in vnd-null mutant embryos at
embryonic stage 15. Laser confocal microscopy reconstructions of optical
sections, lateral views. (A,B) Double-immunolabelling with
anti-HRP antibody (red) and anti-ELAV antibody (yellow/green).
(C,D) Double-immunolabelling with anti-HRP antibody (red) and
glial-specific anti-REPO antibody (yellow/green). Arrows indicate general
trito-deutocerebral region. (E,F) Double immunolabelling with
anti-HRP antibody (red) and an anti-EN antibody (yellow/green). (A) In wild
type, neuron-specific marker ELAV reveals all neural cell bodies. (B) By
contrast, in vnd-null mutants a large gap is seen in the
tritocerebral/deuterocerebral region (arrow). (C) The glia-specific marker
REPO reveals localization of glial cell bodies in embryonic wild-type brain.
(D) In vnd mutant embryos, REPO-expressing cells in residual
tritocerebral/deuterocerebral region appear to be present but are severely
misplaced (arrow). (E) In wild type, the protocerebral b1 en-stripe
(b1), deuterocerebral b2 en-stripe (b2), tritocerebral b3
en-stripe and anteriormost en expressing secondary head spot
(shs) are visible (arrowheads). (F) By contrast, in vnd-null mutant
embryos only b1 en-stripe and en expressing secondary head
spot are present (arrowheads), and neuron-specific HRP marker reveals a
cellular gap in deuto- and tritocerebral region (arrow).